, a Hemophilia treatment by Danish firm Novo Nordisk, may have caused 49 deaths in the United States as well as cardiovascular complications, according to a study published Wednesday in the Journal of the American Medical Association Lrb Jama Rrb.
Novo Nordisk's Hemophilia drug linked to 49 deaths in us.